Press Releases
World Health Organization Authorizes SINOVACs CoronaVac for Emergency Use
SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that CoronaVacยฎ, an innovative, inactivated coronavirus vaccine developed by SINOVAC Life Sciences...
News
Humanigen Submits Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19
Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called โcytokine stormโ with its lead drug candidate, lenzilumab,ย announced...
News
Biological E to produce Providence Therapeutics mRNA COVID-19 vaccine in India
Biological E has entered into an agreement with Canada-based Providence Therapeutics Holdings, to manufacture the latterโs mRNA (messenger Ribonucleic acid) vaccine PTX-COVID19-B in India....
News
Tessol launches cold solutions for vaccine delivery
Tessol has launched a solution for vaccine delivery across India to aid the massive COVID-19 vaccination drive undergoing in the country. The company has...
Drug Research
Engine Biosciences expands its digital drug discovery pipeline with $43M round
Drug discovery is a large and growing field, encompassing both ambitious startups and billion-dollar Big Pharma incumbents. Engine Biosciences is one of the former,...
Clinical Trials
NRx Pharmaceuticals Announces Positive Results for ZYESAMI and Submits EUA Application to US FDA to Treat Critical COVID-19 in Patients
NRx Pharmaceuticals , a clinical stage pharmaceutical company, announced it has filed an application with U.S. FDA requesting Emergency Use Authorization (EUA) for ZYESAMIโข...
News
Moderna Announces Initiation of Rolling Submission of Biologics License Application with U.S. FDA for the Moderna COVID-19 Vaccine
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it has initiated the rolling submission process with the U.S....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















